ASXC
T. Rowe Price Associates’s Asensus Surgical, Inc. ASXC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-185,500
| Closed | -$43K | – | 3062 |
|
|
2024
Q1 | $43K | Hold |
185,500
| – | – | ﹤0.01% | 2892 |
|
|
2023
Q4 | $60K | Hold |
185,500
| – | – | ﹤0.01% | 2780 |
|
|
2023
Q3 | $51K | Hold |
185,500
| – | – | ﹤0.01% | 2773 |
|
|
2023
Q2 | $94K | Hold |
185,500
| – | – | ﹤0.01% | 2705 |
|
|
2023
Q1 | $123K | Sell |
185,500
-40,300
| -18% | -$26.7K | ﹤0.01% | 2645 |
|
|
2022
Q4 | $78K | Sell |
225,800
-70,300
| -24% | -$24.3K | ﹤0.01% | 2757 |
|
|
2022
Q3 | $134K | Buy |
296,100
+86,400
| +41% | +$39.1K | ﹤0.01% | 2657 |
|
|
2022
Q2 | $83K | Sell |
209,700
-21,241
| -9% | -$8.41K | ﹤0.01% | 2789 |
|
|
2022
Q1 | $145K | Buy |
230,941
+33,100
| +17% | +$20.8K | ﹤0.01% | 2771 |
|
|
2021
Q4 | $220K | Buy |
197,841
+71,000
| +56% | +$79K | ﹤0.01% | 2719 |
|
|
2021
Q3 | $235K | Buy |
126,841
+24,600
| +24% | +$45.6K | ﹤0.01% | 2658 |
|
|
2021
Q2 | $324K | Sell |
102,241
-759
| -0.7% | -$2.41K | ﹤0.01% | 2562 |
|
|
2021
Q1 | $335K | Buy |
+103,000
| New | +$335K | ﹤0.01% | 2522 |
|
|
2019
Q4 | – | Sell |
-149,194
| Closed | -$92K | – | 2554 |
|
|
2019
Q3 | $92K | Buy |
149,194
+909
| +0.6% | +$553 | ﹤0.01% | 2448 |
|
|
2019
Q2 | $202K | Buy |
148,285
+927
| +0.6% | +$1.28K | ﹤0.01% | 2403 |
|
|
2019
Q1 | $351K | Buy |
147,358
+36,000
| +32% | +$85.7K | ﹤0.01% | 2238 |
|
|
2018
Q4 | $252K | Sell |
111,358
-288,245
| -72% | -$652K | ﹤0.01% | 2338 |
|
|
2018
Q3 | $2.32M | Buy |
399,603
+290,646
| +267% | +$1.69M | ﹤0.01% | 1582 |
|
|
2018
Q2 | $475K | Buy |
108,957
+34,757
| +47% | +$151K | ﹤0.01% | 2155 |
|
|
2018
Q1 | $126K | Buy |
74,200
+600
| +0.8% | +$1.02K | ﹤0.01% | 2464 |
|
|
2017
Q4 | $142K | Buy |
+73,600
| New | +$142K | ﹤0.01% | 2456 |
|